How can the social and behavioral sciences best inform network trials? The HANC-facilitated Behavioral Science Consultative Group (BSCG) invites you to join BSCG representatives, Dr. Rivet Amico (University of Michigan), Dr. Michele Andrasik (HVTN, University of Washington), and Dr. Jessica Haberer (Harvard Medical School, Massachusetts General Hospital) as they explore social and behavioral science topics. During the webinar, you’ll learn about the applications of social and behavioral science in clinical trial design, implementation, and interpretation (e.g., community engagement, adherence measurement, and collection of other data points of high relevance, understanding outcomes) and hybrid implementation science designs. The presentation will include real-world applications of social and behavioral science in ongoing network trials.
The BSCG was formed in the summer of 2013. There are ten behavioral science researchers that are members of the BSCG. Each NIH HIV/AIDS clinical research network has a representative on the BSCG along with five experts that are not associated with the networks.
The overarching objectives of the BSCG are to provide expert opinion as requested to the NIH HIV/AIDS Clinical Trials Networks on the behavioral components of their research agenda and studies: including, but not limited to, advice on protocol design, protocol implementation and methodology for data collection and evaluation. Examples of issues that can be addressed include the assessment of the interaction of adherence and risk behaviors in prevention studies, as well as the implications to study design of real-time adherence measures and possible interventions based on that data.